Leukine
- Product NDC
- 0024-5843
- 11-digit product format
- 000245843
- Labeler code
- 0024
- Product ID
- 0024-5843_ac281296-b49b-4f33-a16c-a83e60964713
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- SARGRAMOSTIM
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Labeler
- sanofi-aventis U.S. LLC
- Application
- BLA103362
- Marketing category
- BLA
- Marketing start
- 1991-05-01
- Marketing end
- 2021-12-30
- Substance
- SARGRAMOSTIM
- Active strength
- 250 ug/mL
- Pharmacologic classes
- Granulocyte Colony-Stimulating Factor [CS],Granulocyte-Macrophage Colony-Stimulating Factor [CS],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0024-5843-05 | 00024584305 | 5 VIAL in 1 CARTON (0024-5843-05) > 1 mL in 1 VIAL (0024-5843-01) | 5 vial | 1991-05-01 | 2021-12-30 | No | No | Current |